Skip to main content
. Author manuscript; available in PMC: 2024 Dec 2.
Published in final edited form as: Ann Rheum Dis. 2023 May 2;82(8):1091–1097. doi: 10.1136/ard-2023-223873

Figure 2.

Figure 2.

Venn diagram showing the number of genes that were differentially overexpressed (q-value < 0.05) in DM patients with anti-Mi2 autoantibodies compared to other myositis patients and normal muscle biopsies.

DM: dermatomyositis with autoantibodies other than anti-Mi2, AS: antisynthetase syndrome, IBM: inclusion body myositis, IMNM: immune-mediated necrotizing myositis, NT: histologically normal biopsies.